GB915303A - Pyrrolo[2,3-d]pyrimidine derivatives and the manufacture thereof - Google Patents

Pyrrolo[2,3-d]pyrimidine derivatives and the manufacture thereof

Info

Publication number
GB915303A
GB915303A GB8013/59A GB801359A GB915303A GB 915303 A GB915303 A GB 915303A GB 8013/59 A GB8013/59 A GB 8013/59A GB 801359 A GB801359 A GB 801359A GB 915303 A GB915303 A GB 915303A
Authority
GB
United Kingdom
Prior art keywords
group
hydrogen atom
alkyl
pyrrolo
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8013/59A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of GB915303A publication Critical patent/GB915303A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB8013/59A 1958-03-13 1959-03-09 Pyrrolo[2,3-d]pyrimidine derivatives and the manufacture thereof Expired GB915303A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72110458A 1958-03-13 1958-03-13

Publications (1)

Publication Number Publication Date
GB915303A true GB915303A (en) 1963-01-09

Family

ID=24896553

Family Applications (2)

Application Number Title Priority Date Filing Date
GB8013/59A Expired GB915303A (en) 1958-03-13 1959-03-09 Pyrrolo[2,3-d]pyrimidine derivatives and the manufacture thereof
GB32973/61A Expired GB915304A (en) 1958-03-13 1959-03-09 Pyrrolo[2,3-d]pyrimidine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB32973/61A Expired GB915304A (en) 1958-03-13 1959-03-09 Pyrrolo[2,3-d]pyrimidine derivatives

Country Status (3)

Country Link
ES (1) ES247857A1 (US07122547-20061017-C00273.png)
FR (1) FR607M (US07122547-20061017-C00273.png)
GB (2) GB915303A (US07122547-20061017-C00273.png)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007187A (en) * 1973-10-02 1977-02-08 Delalande S.A. Furo (2,3d) pyrimidines
WO1999062518A1 (en) * 1998-06-02 1999-12-09 Osi Pharmaceuticals, Inc. PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
US6096749A (en) * 1994-05-03 2000-08-01 Novartis Corporation Pyrrolopyrimidine derivatives having pharmacological activity
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
JP2005504847A (ja) * 2001-10-04 2005-02-17 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ピリミジン誘導体
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
WO2007084667A2 (en) * 2006-01-19 2007-07-26 Osi Pharmaceutical, Inc. Fused heterobicyclic kinase inhibitors
US7250420B2 (en) 2002-11-26 2007-07-31 Pfizer Inc. Method of treatment of transplant rejection
US7265221B2 (en) 1999-12-10 2007-09-04 Pfizer, Inc. Pyrrolo[2,3-d]pyrimidine compounds
JP2007284455A (ja) * 1998-06-19 2007-11-01 Pfizer Prod Inc ピロロ［２．３−ｄ］ピリミジン化合物
US7501407B2 (en) 2001-12-20 2009-03-10 Osi Pharmaceuticals, Inc. Pyrimidine A2B selective antagonist compounds, their synthesis and use
US7504407B2 (en) 2001-11-30 2009-03-17 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 and A3 receptors and uses thereof
US7569569B2 (en) 1998-06-19 2009-08-04 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds
US7645754B2 (en) 2001-12-20 2010-01-12 Osi Pharmaceuticals, Inc. Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use
US8133899B2 (en) 2008-08-20 2012-03-13 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311628A (en) * 1965-03-09 1967-03-28 Bristol Myers Co Derivatives of pyrrolo [2, 3-d] pyrimidine

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007187A (en) * 1973-10-02 1977-02-08 Delalande S.A. Furo (2,3d) pyrimidines
US6096749A (en) * 1994-05-03 2000-08-01 Novartis Corporation Pyrrolopyrimidine derivatives having pharmacological activity
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
WO1999062518A1 (en) * 1998-06-02 1999-12-09 Osi Pharmaceuticals, Inc. PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
JP2002516861A (ja) * 1998-06-02 2002-06-11 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド ピロロ［２，３ｄ］ピリミジン組成物およびその使用
CZ302486B6 (cs) * 1998-06-02 2011-06-15 Osi Pharmaceuticals, Inc. N-6-Substituovaný 7-deazapurin, zpusob jeho prípravy a farmaceutická kompozice s jeho obsahem
EP2011499A3 (en) * 1998-06-02 2010-10-20 OSI Pharmaceuticals, Inc. Pyrrolo[2,3d]Pyrimidine compositions and their use
US7429574B2 (en) 1998-06-02 2008-09-30 Osi Pharmaceuticals, Inc. 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6800633B2 (en) 1998-06-02 2004-10-05 Osi Pharmaceuticals, Inc. Pyrrolo[2,3d]pyrimidine compositions and their use
AP1411A (en) * 1998-06-02 2005-05-10 Osi Pharm Inc Pyrrolo[2,3d] pyrimidine compositions and their use.
US7687507B2 (en) 1998-06-19 2010-03-30 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds
US7569569B2 (en) 1998-06-19 2009-08-04 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds
JP2012041365A (ja) * 1998-06-19 2012-03-01 Pfizer Products Inc ピロロ［２．３−ｄ］ピリミジン化合物
JP2007284455A (ja) * 1998-06-19 2007-11-01 Pfizer Prod Inc ピロロ［２．３−ｄ］ピリミジン化合物
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US7265221B2 (en) 1999-12-10 2007-09-04 Pfizer, Inc. Pyrrolo[2,3-d]pyrimidine compounds
US7842699B2 (en) 1999-12-10 2010-11-30 Pfizer Inc. Pyrrolo[2,3-D]pyrimidine compounds
USRE41783E1 (en) 1999-12-10 2010-09-28 Pfizer Inc. Pyrrolo[2,3-D]pyrimidine compounds
US7601727B2 (en) 1999-12-10 2009-10-13 Pfizer, Inc. Pyrrolo[2,3-d]pyrimidine compounds
US7598252B2 (en) 2000-12-01 2009-10-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A, receptors and uses thereof
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
JP4782376B2 (ja) * 2001-10-04 2011-09-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ピリミジン誘導体
JP2005504847A (ja) * 2001-10-04 2005-02-17 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ピリミジン誘導体
US7504407B2 (en) 2001-11-30 2009-03-17 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 and A3 receptors and uses thereof
US7645754B2 (en) 2001-12-20 2010-01-12 Osi Pharmaceuticals, Inc. Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use
US7501407B2 (en) 2001-12-20 2009-03-10 Osi Pharmaceuticals, Inc. Pyrimidine A2B selective antagonist compounds, their synthesis and use
US7250420B2 (en) 2002-11-26 2007-07-31 Pfizer Inc. Method of treatment of transplant rejection
WO2007084667A3 (en) * 2006-01-19 2007-12-06 Osi Pharmaceutical Inc Fused heterobicyclic kinase inhibitors
JP2009523812A (ja) * 2006-01-19 2009-06-25 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド 融合へテロ二環式キナーゼ阻害剤
WO2007084667A2 (en) * 2006-01-19 2007-07-26 Osi Pharmaceutical, Inc. Fused heterobicyclic kinase inhibitors
US8133899B2 (en) 2008-08-20 2012-03-13 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds
US8987283B2 (en) 2008-08-20 2015-03-24 Zoetis Llc Pyrrolo[2,3-D]pyrimidine compounds
US9161939B2 (en) 2008-08-20 2015-10-20 Zoetis Services Llc Pyrrolo[2,3-d]pyrimidine compounds
US9271981B2 (en) 2008-08-20 2016-03-01 Zoetis Services Llc Pyrrolo[2,3-D]pyrimidine compounds

Also Published As

Publication number Publication date
FR607M (US07122547-20061017-C00273.png) 1961-06-19
GB915304A (en) 1963-01-09
ES247857A1 (es) 1959-08-16

Similar Documents

Publication Publication Date Title
GB915303A (en) Pyrrolo[2,3-d]pyrimidine derivatives and the manufacture thereof
ES8400422A1 (es) "procedimiento de preparacion de eteres triciclicos, asi como de sus sales de adicion con un acido mineral u organico terapeuticamente compatible".
KR830002759A (ko) 4-아미노-3-카복시 또는 시아노-1,2-디하이드로-2-옥소-1,8-나프티리딘 유도체
DE3065304D1 (en) Morpholine derivatives, pharmaceutical compositions containing them and processes for their preparation
ES8200011A1 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
ES8500948A1 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
GB1120463A (en) Derivatives of 1,3-diazafluoranthene-1-oxide
GB973361A (en) Pyrazolo-pyrimidines and process for their manufacture
ES473181A1 (es) Procedimiento para la preparacion de derivados pirido -1, 2-a pirimidina
TW366343B (en) Piperidine derivatives and anti-platelet agents containing the same
GB1041536A (en) Quaternary ammonium derivatives of dibenzo[a,d]-cycloheptadiene derivatives
GB831920A (en) New phenthiazine derivatives and processes for their preparation
ES478691A1 (es) Procedimiento para la obtencion de un material organico de alto peso molecular aclarado opticamente.
GB968714A (en) Analeptically active n-substituted amino-norcamphane derivatives and their addition salts with acids and their quaternary ammonium compounds
GB1093187A (en) Dibenzothiadiazepine dioxide derivatives
ES8101074A1 (es) Procedimiento para la preparacion de derivados de xantina
ES470087A1 (es) Un procedimiento para la preparacion con compuestos organi- cos de derivados de benzacepina
GB1103718A (en) New dibenzocycloheptadiene derivatives and their preparation
ES451772A1 (es) Un procedimiento para la produccion de dibenzo (b,e) (1,4) diacepinas.
ES8406065A1 (es) Un procedimiento para la preparacion de derivados de trifluormetanosulfonanilida.
GB872320A (en) N-substituted azepines and their production
ES8600203A1 (es) Procedimiento de preparacion de nuevos derivados aminoetoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias
ES443265A1 (es) Un procedimiento para preparar derivados de tiazolina.
ES260976A1 (es) Procedimiento para preparar nuevos compuestos n-heterociclicos
GB925017A (en) Quaternary ammonium compounds and their preparation